United Therapeutics

YTD

ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,305

Employees1,305

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,305

Employees1,305

UTHR Key Statistics

Market cap

13.32B

Market cap13.32B

Price-Earnings ratio

11.98

Price-Earnings ratio11.98

Dividend yield

—

Dividend yield—

Average volume

423.89K

Average volume423.89K

High today

$298.96

High today$298.96

Low today

$295.33

Low today$295.33

Open price

$298.19

Open price$298.19

Volume

288.05K

Volume288.05K

52 Week high

$417.82

52 Week high$417.82

52 Week low

$266.98

52 Week low$266.98

Analyst ratings

67%

of 15 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals

Exelixis

Sprouts Farmers Market

VeriSign

Novo Nordisk

Gilead Sciences